CADL short interest
Candel Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 13,000,504 |
|---|---|
| Change vs prior report | 655,855 (+5.3%) |
| Change over six months | -12.3% |
| Days to cover | 11.15 (sector: 3.78) |
| Average daily volume | 1,165,450 |
| Rank in Healthcare | #85 of 922 by days to cover |
CADL short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 13,000,504 | +5.3% | 11.15 | 1,165,450 |
| 2026-09-15 | 12,344,649 | +0.7% | 10.28 | 1,201,218 |
| 2026-08-31 | 12,265,275 | -1.6% | 9.19 | 1,334,072 |
| 2026-08-14 | 12,463,333 | -1.5% | 10.56 | 1,180,656 |
| 2026-07-31 | 12,655,457 | -2.4% | 10.41 | 1,215,993 |
| 2026-07-15 | 12,961,675 | -19.7% | 9.01 | 1,438,489 |
| 2026-06-30 | 16,135,706 | +18.5% | 5.98 | 2,697,760 |
| 2026-06-15 | 13,617,030 | -3.9% | 7.58 | 1,797,046 |
| 2026-05-29 | 14,163,766 | -1.8% | 7.64 | 1,854,979 |
| 2026-05-15 | 14,424,891 | -1.8% | 5.54 | 2,601,558 |
| 2026-04-30 | 14,681,430 | -2.6% | 6.41 | 2,289,498 |
| 2026-04-15 | 15,067,083 | +1.7% | 15.51 | 971,257 |
| 2026-03-31 | 14,816,272 | +4.5% | 11.71 | 1,265,277 |
| 2026-03-13 | 14,182,716 | +9.2% | 11.12 | 1,275,494 |
| 2026-02-27 | 12,985,515 | +39.7% | 6.76 | 1,921,439 |
| 2026-02-13 | 9,295,851 | -0.7% | 15.91 | 584,101 |
| 2026-01-30 | 9,356,491 | +0.4% | 12.59 | 743,077 |
| 2026-01-15 | 9,323,140 | +1.4% | 12.97 | 718,793 |
| 2025-12-31 | 9,190,578 | +10.4% | 14.58 | 630,229 |
| 2025-12-15 | 8,327,222 | +0.7% | 6.63 | 1,256,478 |
| 2025-11-28 | 8,272,637 | -0.9% | 11.87 | 696,763 |
| 2025-11-14 | 8,344,526 | +11.6% | 13.19 | 632,705 |
| 2025-10-31 | 7,479,907 | +0.1% | 10.48 | 713,961 |
| 2025-10-15 | 7,473,390 | +3.5% | 7.69 | 971,994 |
| 2025-09-30 | 7,222,409 | -2.9% | 9.54 | 756,949 |
import finzdata as yf
yf.Ticker("CADL").short_interest # every report since 2017
yf.Client().short_interest(["CADL"], start="2018-01-01")Healthcare short interest · CADL price history · Who owns CADL · All short interest